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ABSTRACT: Protein nanopores have been used as stochastic sensors
for the detection of analytes that range from small molecules to proteins.
In this approach, individual analyte molecules modulate the ionic current
flowing through a single nanopore. Here, a new type of stochastic sensor
based on an αHL pore modified with an aptamer is described. The
aptamer is bound to the pore by hybridization to an oligonucleotide that
is attached covalently through a disulfide bond to a single cysteine
residue near a mouth of the pore. We show that the binding of thrombin
to a 15-mer DNA aptamer, which forms a cation-stabilized quadruplex,
alters the ionic current through the pore. The approach allows the
quantification of nanomolar concentrations of thrombin, and provides association and dissociation rate constants and equilibrium
dissociation constants for thrombin·aptamer interactions. Aptamer-based nanopores have the potential to be integrated into
arrays for the parallel detection of multiple analytes.
■ INTRODUCTION
Stochastic sensors based on nanopores are under intense
investigation.
1−7 In this approach to single-molecule detection,
the reversible interaction of an analyte with a pore alters the
current flowing through it, which is carried by aqueous ions.
The change in the current amplitude and the mean dwell time
of the analyte reveal the analyte’s identity, while the number of
events per unit time yields the analyte concentration.
2 Modified
pores that bind specific analytes or families of analytes are
especially useful for stochastic detection. In this regard
engineered protein pores, notably staphylococcal α-hemolysin
(αHL), have been most effective.
2 The αHL pore has been
used to detect metal ions,
8−10 small molecules,
11,12 reactive
molecules,
13 DNA,
14 and proteins.
15−18
Because proteins are too large to bind within the lumen of
the αHL pore, various approaches have been taken to transmit
binding events occurring outside the pore to the interior so that
the ionic current is altered. In one example, one end of a
polymer was covalently attached within the αHL pore, while a
ligand was attached the other end, which was free to explore the
nearby buffer. The reversible binding of proteins in either the
cis or trans solution (Figure 1) was detected as a dampening of
the fluctuations of the polymer within the pore, manifested as
decreased current “noise”.
15 Lectins have been detected after
the attachment of disaccharides near the cis entrance of the
pore. In this case, binding resulted in a decrease in the ionic
current.
16 Protein kinases have been detected after equipping
the αHL pore with a protein kinase inhibitor peptide, attached
chemically
17 or by using a genetic insert,
18 in both cases near
the trans entrance. In the first case, the binding of a kinase
subunit caused a current block.
17 In the second case, kinase
binding caused both a current block and diminution of current
noise arising from movement of the insert near the entrance to
the pore.
18
In the present work we describe a different approach for
protein detection by stochastic sensing that provides a flexible
means to change the detecting ligand. First, a short DNA
oligonucleotide is covalently attached to a cysteine residue
near the entrance of the nanopore through a disulfide bond
(Figure 1a);
14,19,20 the oligonucleotide acts as an adapter to
which various nucleic acid ligands can be coupled by duplex
formation.
14,19,20 One class of nucleic acid ligands encompasses
aptamers, which are DNA or RNA oligonucleotides that
adopt three-dimensional structures capable of binding various
analytes, including small molecules, proteins, and even cells.
21,22
Aptamers have been used as biosensor components
23 or as
therapeutic agents.
24
Aptamers are selected in vitro by using SELEX (systematic
evolution of ligands by exponential enrichment).
25,26 The
starting point for SELEX is a large library of randomized
oligonucleotide sequences (>1013). A selection and amplifica-
tion process is repeated until oligonucleotides with high affinity
for the target have been obtained.
25,26 In the present work,
thrombin has been chosen as a target analyte. Its interactions
with various aptamers have been detected previously by using
various analytical devices (e.g., capillary electrophoresis, surface
plasmon resonance, MALDI mass spectrometry
27), none of
which operate at the single molecule level.
Ding and colleagues attached multiple aptamers near the
mouth of a narrow glass micropipet and were able to record a
series of individual but irreversible binding events for both IgE
and ricin.
28 Here, we use a 15-mer DNA aptamer,
29 which
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30−32 that binds thrombin
reversibly and is therefore suitable for continuous real-time
sensing. Because it is a simple matter to change the oligonu-
cleotide that is hybridized to the adapter, we could rapidly
compare the properties of various versions of the aptamer. We
suggest that the approach might be applied to the fabrication of
sensor arrays.
■ RESULTS AND DISCUSSION
DNA Oligonucleotide Attachment to the αHL Nano-
pore. An 18-mer DNA oligonucleotide (oligoA) was attached
to the αHL N17C monomer through a disulfide bond to Cys-
17. Cys-17 is the only cysteine residue in this polypeptide since
the wild-type αHL contains no cysteine residues. About 70%
of the N17C subunits were derivatized as determined by the
mobility shift in SDS-polyacrylamide gels (Figure 1b). The
modified N17C monomers were mixed with excess WT
monomers and assembled in the presence of rabbit red blood
cell membranes to form heteroheptameric pores, which are
stable toward SDS.
33 The pores with more oligonucleotides
migrated faster (Figure 1c). αHL WT617C1 heteromeric
pores with oligoA attached near the cis entrance (Figure 1a)
were extracted from the gel (band II, Figure 1c). Previous
results suggest that monomers with additional negative charge
usually migrate more slowly in SDS gels, while heptamers with
additional negative charge usually migrate more rapidly.
14,33
Although there is no simple explanation of this finding, the
present results are consistent with the phenomenon. On the
basis of SDS-PAGE of denatured pores (lane II, Figure 1d) and
the properties of the pores during single-channel recording
(see below), it was concluded that a single copy of oligoA
was attached to a large majority of the pores recovered from
band II (WT617C-oligoA1). The underivatized N17C sub-
units in band II must represent subunits from which DNA
has become detached or N17C from WT517C117C-oligoA1,
which would migrate to the same position. In the following,
we assume that WT517C117C-oligoA1 has the same electrical
Figure 1. Attachment of a single DNA oligonucleotide to the αHL pore. (a) Cross-section of a model showing an αHL pore chemically modified
with a single DNA oligonucleotide. The oligonucleotide is attached by a hexamethylene linker and a disulfide bond to Cys-17 of a single genetically
engineered subunit within a heptameric αHL pore. The model was made with PyMOL software (www.pymol.org) based on the pdb files 7AHL
(αHL, gray) and 3IAG (ssDNA, light blue). (b) Autoradiogram of an SDS-polyacrylamide gel (Criterion XT Precast Gel, 10% acrylamide) showing
αHL N17C monomers before (lane 1) and after (lane 2) reaction with the activated oligoA oligonucleotide. Schematic representations of αHL
N17C monomers with and without an attached oligoA are shown. (c) Autoradiogram of an SDS-polyacrylamide gel (Tris.HCl gel, 5% acrylamide)
showing unheated samples of αHL heptamers formed on rabbit red blood cell membranes with a mixture of 35S-labeled N17C-oligoA monomers and
excess unlabeled WT monomers. Schematic representations of αHL pores with 0, 1, or 2 attached oligoA oligonucleotides are shown. (d)
Autoradiogram of an SDS-polyacrylamide gel of polypeptides found in the bands from part c. The samples were extracted from the first gel,
denatured (10 min, 95 °C in XT sample buffer, Bio-Rad) and run in second gel (Criterion XT Precast Gel, 10% acrylamide). Note that the mobility
of heptameric αHL in SDS-polyacrylamide gels is increased after modification with DNA, while the mobility of monomers is decreased by DNA
attachment.
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αHL-oligoA1.
Aptamer Hybridization to the DNA Adapter. Single-
channel recordings at +50 mV of the unhybridized αHL-
oligoA1 pore showed short and frequent current blockades
(Figure 2b). These events represent transient movements of
oligoA into the pore. As the applied potential was increased, the
dwell times of these events increased, and eventually (at above
+100 mV) oligoA was permanently located inside the pore
(Figure S1).
AptamerT4, which includes (5′ to 3′) a complementary
sequence to oligoA (15 nt), a thymine linker (4 nt), and a
thrombin-binding domain (15 nt) (Figure 2a), was hybridized
to the oligoA adapter of αHL-oligoA1 before the protein was
added to the cis chamber. With hybridized aptamerT4, two
blockade levels were observed at +50 mV: B1 (43 ± 1% current
block, n = 7) and B2 (76 ± 2% current block, n = 7) (Figure 2c,
Table 1). Various experiments were carried out to identify the
sources of current block. Single-channel recording of αHL
pores that were directly coupled to a thiolated thrombin
aptamer showed only blocking events with a current level
Figure 2. αHL pore with a thrombin aptamer attached by DNA hybridization. (a) The DNA duplex formed between oligoA and aptamerT4. (b, c)
Representative single-channel recordings from the αHL-oligoA1 pore (b) before and (c) after hybridization to aptamerT4. The measurements were
performed in 1 M KCl, buffered with 10 mM Tris.HCl, pH 7.2, at +50 mV. The traces were filtered at 1 kHz. The models are based on pdb files
7AHL (αHL, gray), 3IAG (dsDNA, light blue and orange), and 148D (thrombin aptamer, red). Before hybridization to the DNA duplex, the DNA
adapter moves in and out of the pore creating short, frequent blocking events as seen in part b. After hybridization of the aptamer, two blockade
levels are observed, B1 and B2, as shown in part c. The B1 level is generated by movement of the quadruplex domain into the vestibule of the pore,
while the B2 level arises from the insertion of the dsDNA segment into the pore (see the text).
Table 1. Transitions between Current Levels in αHL-
oligoA1·AptamerT4 Pores
a
current level B1 % block: 43 ± 1% current level B2 % block: 76 ± 2%
transition rate (s ‑1) transition rate (s ‑1)
b
UB to B1 0.49 ± 0.22 UB to B2 0.18 ± 0.19
B1 to UB 2.1 ± 0.6 B2 to UB 7.6 ± 14.5
aThe measurements were made in 1 M KCl, 10 mM Tris.HCl, pH 7.2,
at +50 mV. Values are the mean ± s.d. (n = 7).
bThe rate of the
transitions UB to B2 and B2 to UB were highly diverse: UB to B2,
0.05−0.58 s−1; B2 to UB, 0.7−40 s−1 (Figure S4).
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that the B1 level is generated by insertion of the aptamer’s
quadruplex into the pore vestibule. The result is consistent with
the finding of Shim and colleagues who showed that a free
thrombin aptamer can enter the vestibule of the αHL pore
and partially block the ionic current.
34,35 By contrast, when
oligonucleotides that contained only a hybridization domain
(Figure S3a), or contained a hybridization domain and a 19-
mer extension that cannot form a quadruplex (Figure S3b),
were hybridized to αHL-oligoA1, blocking events with current
levels similar to B2 were observed. This suggests that B2
represents the insertion of the double-stranded portion of the
hybridized structures into the pore vestibule. The rate of the
transitions to and from current level B2 varied greatly from
pore to pore, regardless of which oligonucleotide was
hybridized to the adapter (Figure S4), and we have no
explanation for this phenomenon, other than the unpersuasive
supposition that the pore structures differ subtly. The
amplitude of the B2 blockade, and the amplitudes and kinetics
of the other blockades were not subject to this kind of variation.
Importantly, the rates of the transitions to and from B2 did not
affect thrombin detection by the aptamer (see below).
The frequency of the transitions to level B1 (aptamer
insertion into the pore) and the dwell time in this level
increased as the applied potential was raised (Figure S5). At
high positive potentials (e.g., +80 mV, Figure S5), a new
current level was observed for a short time (94% current block,
arrow, Figure S4). Subsequently, fast transitions to and from
another new current level (89% block) were observed (Figure
S5). When the potential was dropped back to +50 mV, the
activity pattern of αHL-oligoA1 without aptamerT4 was
observed (compare Figure 2b and Figure S5). These results
suggest that at high potentials the hybridized DNA is stripped
from oligoA.
Aptamer−Thrombin Interactions. After thrombin had
been added to the cis chamber, single-channel recordings of
αHL-oligoA1·aptamerT4 pores revealed a new class of events
with an increased current amplitude (level UB+T, Figure 3b).
These events were not observed when the thrombin was
denatured before addition or when bovine albumin serum was
used instead (data not shown), which suggests that the events
are caused by the interaction of folded thrombin with the
attached aptamer. As expected, the addition of excess free
aptamers to the cis chamber (after the addition of thrombin)
caused a reduction in the frequency of occurrence of the UB+T
events (Figure S6). It is not clear why thrombin binding to the
aptamer increases the ionic current through the pore. Ion flow
could be affected by the presence of charged residues on the
surface of the bound thrombin or by a change in the position of
the aptamer at the pore entrance caused by thrombin binding.
The thrombin binding events have only a minor effect on the
ionic current that passes through the pore (∼1% increase,
Figure 3b). Therefore, a high salt concentration (1 M KCl in
both chambers) was used to allow the events to be detected
above the noise level. Interestingly, the Kd value for the
thrombin·aptamer complex on the nanopore was similar to
values obtained at lower salt concentrations with other methods
(see below).
The presence of thrombin in the cis chamber also reduced
the frequency of the transitions into the B1 level (Figures 3b
and S7). Inspection of the recording traces revealed that the
transitions into B1 occurred only from the unblocked current
Figure 3. Detection of the interactions between thrombin and aptamerT4. Representative single-channel recordings of αHL-oligoA1·aptamerT4 (a)
before and (b) after the addition of 80 nM thrombin (final concentration) to the cis chamber. The measurements were performed in 1 M KCl,
buffered with 10 mM Tris.HCl, pH 7.2, at +50 mV. In the presence of thrombin, a new elevated current level (UB+T) was observed and the
frequency of the B1 blockades was reduced. The upper panels are enlargements of the gray boxes in the lower panels. The traces were filtered at
50 Hz. (c) A kinetic model for the transitions between the various currents levels observed in the presence of thrombin. The models are based on
pdb files 7AHL (αHL, gray), 3IAG (dsDNA, light blue and orange), 148D (thrombin aptamer, red), and 1HUT (thrombin and thrombin·aptamer
complex, green and green plus red, respectively).
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transitions into B2 occurred from both UB and UB+T and were
not affected by the thrombin binding events (Figure S7 inset,
Figure S8). A kinetic model for the transitions between the
various currents levels is proposed (Figure 3c). On the basis of
this model, the binding of thrombin prevents entry of the
aptamer into the pore vestibule (transitions to B1). However, it
does not affect entry of the double-stranded domain of the
oligoA·aptamerT4 duplex (transitions to B2).
Properties of Various Aptamer Oligonucleotides. In
the present approach, different detection units can be quickly
coupled to the adapter, oligoA. We took advantage of this to
compare the properties of three additional aptamer oligonu-
cleotides. Two have different linkers, with one or seven thy-
mines (aptamerT1 and aptamerT7, respectively) (Figure 4a).
The fourth aptamer oligonucleotide (aptamerΔ3) has a 4-nt
thymidine linker, but the aptamer has been shifted three
nucleotides away from the pore entrance compared to the
others by shortening the hybridization domain to 12 nt (Figure
4a). Both B1 and B2 levels were observed for each of the four
aptamer oligonucleotides. At a potential of +50 mV, aptamerT1
gives a B1 blockade with a 50 ± 3% current reduction,
compared to a ∼40% current reduction with the other aptamer
oligonucleotides (aptamerT4, 43 ± 1%; aptamerT7, 41 ± 2%;
aptamerΔ3, 42 ± 3%). Possibly, the shortest linker restricts the
aptamer quadruplex to a smaller volume of the pore vestibule,
closer to the entrance, than is allowed by the longer linkers.
The frequency of the transitions into current level B1 decreased
as the linker length increased (Figure 4c). In addition, the fre-
quency of the events was reduced when the aptamer was shifted
away from the pore entrance (aptamerT4 versus aptamerΔ3,
Figure 4c). These results suggest that the restriction of the
aptamer to the vicinity of the pore entrance with a short linker
eases its entry to the pore. The rate of the transition of the
aptamer out of the pore (Figure 4d) was slower the longer the
linker; the B1 dwell times increased from ∼10 ms for aptamerT1,
to ∼500 ms for aptamerT4, to ∼10000 ms for aptamerT7.
Shifting aptamerT4 away from the pore entrance by three
nucleotides (aptamerΔ3) reduced the B1 dwell time to ∼250
ms. These results suggest that the deeper within the pore
the aptamer is located, the longer the period of residence. The
linker length and its location did not have a significant influence
on the amplitude of the B2 current blockades (Figure S4).
This is not surprising, since the B2 blockades are derived
from the insertion of duplex DNA into the pore opening, and
the amplitude of the block is similar to that found with
duplex-forming oligonucleotides without the aptamer sequence
(Figures S2a, S3).
Can the three additional aptamer oligonucleotides also sense
thrombin binding? In the case of aptamerT1 (Figure S9), a
Figure 4. Nature of the linker between the hybridization and the aptamer domains affects aptamer insertion into the pore vestibule. (a) Sequences
and representative traces of αHL-oligoA1 pores hybridized with various aptamer oligonucleotides: aptamerT1, aptamerT4, aptamerT7, and
aptamerΔ3. The measurements were performed in 1 M KCl, 10 mM Tris.HCl, pH 7.2, at +50 mV. The traces were filtered at 1 kHz. (b) Kinetic
model describing the observed transitions. (c) Rates of the transitions from UB to B1. (d) Rates of the transitions from B1 to UB. The models are
based on pdb files 7AHL (αHL, gray), 3IAG (dsDNA, light blue and orange), and 148D (thrombin aptamer, red). All measurements were
conducted at least 3 times.
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(UB+T, Figure 3b). However, when thrombin was added
to pores carrying aptamerT7 or aptamerΔ3, the differences
between the UB and UB+T current levels were harder to
distinguish even after filtration of the single-channel recording
traces at 50 Hz (Figure S9). In addition, we also positioned the
aptamer at the opposite end of the DNA duplex, so that it was
located about 4.5 nm away from the pore entrance (Figure
S10). In this case, a blockade at about the level of B2 was
observed and no thrombin binding events were detected
(Figure S10). Therefore, to detect the interactions between the
aptamer and thrombin, the aptamer must be restricted to the
pore entrance with a carefully adjusted short linker.
Kinetics and Thermodynamics of the Thrombin·
Aptamer Interaction. On the basis of the proposed kinetic
model (Figure 3c), the rate constants for the aptamer·thrombin
interactions were determined for aptamerT1 and aptamerT4,
by observing the transitions between the UB and UB+T levels
at different thrombin concentrations, and found to be similar
(Figure 5). The association rate constants were kon = 1.20 ±
0.14 × 107 M−1 s−1 (n = 3) for aptamerT1 and kon = 1.97 ± 0.01
× 107 M−1 s−1 (n = 4) for aptamerT4. The dissociation rate
constants were koff = 1.5 ± 0.2 s−1 (n = 3) for aptamerT1 and
koff = 1.5 ± 0.1 s−1 (n = 4) for aptamerT4. These results also
give us information about the sensor sensitivity. At the lowest
thrombin concentration tested (20 nM), aptamer·thrombin
interactions occur at about 2 s−1 (Figure 5); i.e., we can assay
thrombin, a model protein in the present approach, at low nM
concentrations in as little as a few minutes.
On the basis of the rate constants found for aptamerT4 and
aptamerT1, equilibrium dissociation constants of Kd =7 7±
6 nM and Kd = 126 ± 34 nM were calculated. These values
are similar to Kd values for the thrombin·aptamer interac-
tion determined previously by other approaches (20−
450 nM).
29,36−41 The kinetics of the thrombin·aptamer
interaction have been determined by surface plasmon resonance
(SPR), where the binding of free thrombin to a biotinylated
aptamer immobilized on a streptavidin-coated surface was
measured,
42−44 and by various capillary electrophoresis (CE)
techniques
38,41 (Table S1). These results gave a wide range of
values (Table S1). Single-molecule measurements of ligand·ana-
lyte interactions with nanopores have some advantages over
these ensemble techniques. For example, the measurements do
not suffer from steric hindrance due to crowding of the binding
sites, which can occur on the surface of an SPR chip.
45 Further,
in the nanopore approach, the detector is functional only when
an active ligand is attached to the nanopore. By comparison, in
ensemble measurements, it is common to have a mixture of
active and inactive ligands in an unknown ratio (for example, see
Gong et al.
41). In addition, in the technique presented here, the
analyte·ligand interaction occurs in a static chamber; it is not
dependent on a molecular flow rate, which can bias the
measurement accuracy in SPR and CE. For example, when the
analyte flow rate in SPR is too slow, an analyte molecule can
rebind to the chip surface and as a result complicate the analysis
of the interaction kinetics.
45
■ CONCLUSIONS
We have demonstrated that a protein nanopore equipped with
a DNA adapter can be hybridized with various oligonucleotides
that have different properties. Therefore, the same nanopore
construct might be used to detect different analytes, depending
on the detection unit that is hybridized to it. By contrast, when
the detection unit is directly covalently attached to the nano-
pore,
15−17 a sensor for each analyte must be made separately in
a more laborious fashion. With the development of new ap-
proaches for building bilayer
46−48 and nanopore
49 arrays, it will
be possible to build arrays of nanopores modified with DNA
adapters attached to different detection units for the parallel
detection of a variety of analytes in a single sample.
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